-1.76%
Today
Loading 1D prices…
Company profile
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Parsippany, NJ, United States
Employees
191
Fiscal year end
1231
CIK
1410098
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ASMBAssembly Biosciences Inc. Common Stock | $606.7M | $72.3M | -8.47% | -$0.55 | -2.17% | Buy |
| BLSMBlossomHill Therapeutics Inc. Common Stock | $606.6M | $0.00 | — | -$2.08 | -1.67% | Buy |
| EVOEvotec SE American Depositary Shares | $614.8M | — | — | -$0.29 | -2.26% | Hold |
| MPLTMapLight Therapeutics Inc. Common Stock | $602.9M | $0.00 | — | -$18.56 | -5.84% | Buy |
| DRUGBright Minds Biosciences Inc. Common Stock | $619.9M | — | — | -$1.78 | -2.80% | Buy |